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Abstract 
Objective: To translate into Portuguese, back-translate, culturally adapt and validate a screening instrument for pervasive developmental 
disorder, the Autism Screening Questionnaire, for use in Brazil. Method: A sample of 120 patients was selected based on three groups 
of 40: patients with a clinical diagnosis of pervasive developmental disorder, Down syndrome, or other psychiatric disorders. The self-
administered questionnaire was applied to the patients’ legal guardians. Psychometric measures of the final version of the translated 
questionnaire were tested. Results: The score of 15 had sensitivity of 92.5% and specificity of 95.5% as a cut-off point for the diagnosis 
of pervasive developmental disorder. Internal validity for a total of 40 questions was 0.895 for alpha and 0.896 for KR-20, ranging from 
0.6 to 0.8 for both coefficients. Test and retest reliability values showed strong agreement for most questions. Conclusions: The final 
version of this instrument, translated into Portuguese and adapted to the Brazilian culture, had satisfactory measurement properties, 
suggesting preliminary validation proprieties. It was an easy-to-apply, useful tool for the diagnostic screening of individuals with pervasive 
developmental disorder.
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Resumo
Objetivo: Tradução, retro-versão, adaptação cultural e validação do Autism Screening Questionnaire para a língua portuguesa e para 
o seu uso no Brasil. Método: Foi selecionada uma amostra inicial de 120 pacientes, encaminhados de duas clínicas privadas e uma 
pública, divida em três grupos de 40 pacientes distintos: pacientes com diagnóstico clínico de transtornos globais do desenvolvimento 
ou transtornos invasivos do desenvolvimento; de síndrome de Down e de outros transtornos psiquiátricos. O questionário foi aplicado 
aos responsáveis legais dos pacientes seguindo os padrões de um questionário auto-aplicável. As medidas psicométricas do questio- 
nário traduzido, na sua versão final, foram testadas. Resultados: Valores de sensibilidade de 92,5% e especificidade de 95,5% foram 
encontrados para uma pontuação de 15, como sendo um valor discriminativo para os sujeitos com características de transtornos 
globais do desenvolvimento/transtornos invasivos do desenvolvimento. A validade interna para o total das 40 questões foi de 0,895, 
com uma variação entre 0,6 a 0,8. Os valores de confiabilidade obtidos pelo teste e re-teste demonstraram que a maioria das questões 
obteve alta concordância. Conclusões: A versão final do instrumento de pesquisa, traduzido e adaptado à cultura brasileira, apresentou 
propriedades de medida satisfatórias, sugerindo adequadas propriedades preliminares de validação. É um instrumento de fácil aplica-
ção e uma ferramenta útil para a realização de um screening diagnóstico em indivíduos com transtornos globais do desenvolvimento/
transtornos invasivos do desenvolvimento. 
Descritores: Transtornos globais do desenvolvimento; Transtorno autístico; Estudos de validação; Questionários; Diagnóstico clínico
Fábio Pinato Sato1, Cristiane Silvestre Paula2, Rosane Lowenthal2, 
Eduardo Yoshio Nakano3, Décio Brunoni2, José Salomão Schwartzman2, 
Marcos Tomanik Mercadante4 
Correspondence
Fábio Pinato Sato
Rua Capote Valente, 432/24
05409-001 São Paulo, SP, Brazil
Phone/Fax: (+55 11) 3064-1278
E-mail: fpsato@uol.com.br
Rev Bras Psiquiatr. 2009;31(1):30-3
1  Graduate Program, Department of Psychiatry, Universidade de São Paulo (USP), São Paulo (SP), Brazil
2  Graduate Program in Developmental Disorders, Universidade Presbiteriana Mackenzie, São Paulo (SP), Brazil
3  Department of Statistics, Universidade de Brasília (UNB), Brasília (DF), Brazil
4  Department of Psychiatry, Child and Adolescent Medical Psychiatric Unit, Universidade Federal de São Paulo (Unifesp), São Paulo (SP), Brazil
Submitted: April 16, 2008
Accepted: July 14, 2008
30 BRIEF REPORT
Artigo 06_RBP 290_V07.indd   30 09.03.09   11:37:47
Rev Bras Psiquiatr. 2009;31(1):30-3
Instrument to screen PDD 31
Introduction
Pervasive developmental disorders (PDD) are a series of conditions 
characterized by deficits in the development of sociability and 
communication and by a restricted behavioral pattern. A prevalence 
of 1% has been reported when expanded diagnostic criteria were 
used1. A pilot study conducted in our region suggested a prevalence 
close to the lower limit of rates found in the literature2. 
There are two partially validated instruments for the diagnosis 
of PDD in Brazil: The Autistic Traits of Evaluation Scale (ATA)3 and 
Autism Behavior Checklist (ABC)4. The widespread use of ASQ in 
the literature and its good performance in discriminating individuals 
with PDD from others5 were the main reasons to choose this 
instrument. This study was conducted to translate into Portuguese, 
back-translate, culturally adapt and validate the Autism Screening 
Questionnaire (ASQ)5 for use in Brazil.
Method
The original ASQ was translated into Portuguese and adapted by 
specialists in the medical area. After this stage, the questionnaire 
was back-translated by a bilingual professional. The material was 
presented to three child and adolescent psychiatrists, who are not 
participating in the study. At the end of the process, translators 
and the committee agreed that semantic, idiomatic and cultural 
equivalence was satisfactory, as previously suggested by others6,7. 
The semantic structure of ASQ was not altered either in the 
translation process into Portuguese or in the back-translation into 
English (exception for minor changes in questions 14 and 33). 
After this process, the instrument was applied to the legal 
guardians of 120 children divided into three groups of three different 
work settings (two private and one public) in which patients were 
receiving medical care. Based on the lack of internationally validated 
instruments for the diagnosis of PDD in Brazil, clinical criteria, 
according to DSM-IV, were chosen to classify all the subjects. 
The three groups were comprised of 40 children with a clinical 
diagnosis of PDD (PDDG), 40 children with Down syndrome (control 
for cognitive performance – DownG), and 40 children meeting 
diagnostic criteria for other psychiatric disorders (anxiety, depression, 
attention deficit disorder with or without hyperactivity, without PDD – 
PchG). All 120 children were selected based on order of presentation 
at these three clinics during a 4 week period of time. A pretest was 
applied to evaluate children with Down syndrome8. 
The participants’ guardian was contacted by phone and the 
investigator explained that the study consisted of 40 yes/no 
questions about the patient’s life history. As all selected cases 
agreed to participate, we sent a written informed consent by mail 
and an investigator applied the questionnaire (mean time was 20 
minutes). The patient’s guardian signed the form and mailed it back 
to the investigator. The study was approved by the Institutional 
Research Ethics Committee from Universidade de São Paulo 
Medical School.
After 6 months, the questionnaire was applied again by the same 
investigator to 10 randomly selected participants in each group.
The Statistical Package for the Social Sciences 11.5 (SPSS) for 
Windows was used for statistical analyses. Mean scores (MS) for 
each diagnosis were calculated, and the ANOVA and Tukey post-hoc 
test were used to compare these means. A ROC (Receiver Operating 
Characteristics) curve was obtained indicating several cut-off points 
according to sensitivity and specificity levels. The Kuder-Richardson 
KR-209 and Cronbach’s alpha coefficients10 were used to assess 
internal consistency of the entire questionnaire and of the three 
domains individually. Cohen’s kappa coefficient11 was used to 
measure questionnaire reliability. Frequencies were compared using 
the chi-square test. The level of significance was set at α = 0.05 
or 5% for all statistical tests.
Results
Each group had 40 participants, and their mean ages were 11.1 
years in the PchG (27 boys), 9.9 years in the DownG (22 boys), 
and 9.8 years in the PDDG (34 boys). 
MS varied according to diagnosis. In patients in the PchG, MS 
was 7.2 (SD = 4.1); in the DownG, 9.0 (SD = 4.2); and in the 
PDDG, 21.7 (SD = 5.4). ANOVA revealed a significant difference 
between means (F = 116.7; p < 0.001). According to the post-
hoc test, only PDDG had an MS significantly greater than that of 
the other groups (p < 0.001 for DownG and p < 0.001 for PchG). 
The DownG had an MS slightly greater than that of the PchG, but 
the difference was not statistically significant (p = 0.203). 
Sensitivity and specificity analysis showed that the area under the 
ROC curve was 0.981 (SE = 0.011; p < 0.001). The cut-off point 
of 14.5 (individuals were classified as having PDD if their score was 
≥ 15) had sensitivity of 92.5% and specificity of 95.0%. This cut-off 
point presented balanced levels of sensitivity and specificity.
1. Analysis of both control groups
In individuals with PDD, MS was 21.7 (SD = 5.4); for the total 
control group (TCG = DownG + PchG), it was 8.1 (SD = 4.2). 
The t test confirmed a significant difference between these means 
(t = 13.85; p < 0.001). 
 
2. Internal validity
The analysis of internal validity showed alpha = 0.895 and 
KR-20 = 0.896 for the entire questionnaire. Alpha values varied 
from 0.621 to 0.838 when questions were separated according to 
domains: language (0.687); behavior (0.621); sociability (0.838), 
while KR-20 values varied from 0.625 to 0.840: language (0.685); 
behavior (0.625) and sociability (0.840).
3. Retest reliability (Cohen’s kappa coefficient)
The questionnaire was applied again to PchG and PDDG 
after about 240 days and to DownG at about 730 days 
after the initial test. No control patients had a score above 
the cut-off point, and all patients had scores that indicated 
PDD at retest. Only one patient in the DownG, who had 
scored 18 in the first ASQ application (the patient was not 
able to talk then), scored 7 in the retest application. The 
MS DownG was 7.7 (SD = 4.373; SE = 1.383) at time 
point 1 and 6.6 (SD = 2.914; SE = 0.921) at time point 2 
(t = 0.884; df = 9; p = 0.421); for PchG, 7.2 (SD = 2.898; 
SE = 0.917) at time point 1 and 5.7 (SD = 3.302; SE = 1.044), 
at time point 2 (t = 0.183; df = 9; p = 0.859); and for PDDG, 21.7 
(SD = 5.971; SE = 1.888) at time point 1 and 24.1 
(SD = 6.082; SE = 1.923) at time point 2 (t = 1.500; 
df = 9; p = 0.168). 
Question 5 had the weakest agreement (kappa = 0.374; 
p = 0.045), and question 16 the strongest (kappa = 0.927; 
p < 0.001). Only nine questions had kappa below 0.6 
(# 5 = 0.374; 9 = 0.426; 22 = 0.426; 7 = 0.485; 25 = 0.533; 
11 = 0.561; 31 = 0.571; 21 = 0.583; 24 = 0.598).
The comparison of each question in all three groups showed that 
questions 1, 5, 7, 13 and 23 had no significant prevalence (or 
absence) of answer “1” for one of the diagnosis (p > 0.05); they 
were, therefore, questions with lower classification power.
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Discussion
The analysis of ASQ psychometric properties revealed that it has 
good sensitivity and specificity and that it can discriminate cases of 
PDD from cases of other psychiatric disorders or mental deficiency. 
Moreover, the values found in retesting, which showed 100% 
diagnostic agreement in tests applied at least 8 months after the 
initial application, suggest excellent agreement12,13.
The ATA3 and the ABC4 were the only scales available in Portuguese 
before this study. The ATA was applied to a sample of 61 children 
aged 2-18 years, 30 with autism and 31 with moderate mental 
deficiency. The analysis of external validity showed that the agreement 
with DSM-IV criteria was weak (kappa = 0.04); therefore, the 
data obtained with that instrument could not be generalized for the 
general population. Conversely, internal validity was 100%, which 
indicated strong agreement between clinical diagnosis and the 
diagnosis provided by that scale. That scale had a sensitivity of 0.96 
according to DSM-IV criteria, and Cronbach’s alpha was 0.7110. The 
ABC was applied to three groups, 38 mothers of children diagnosed 
with autism; 43 mothers of children with language disorders other 
than autism and 52 mothers of children who had no linguistic or 
behavioral complaints. The ABC correctly identified 81.6% of the 
autistic children. The cut-off value was 49, sensitivity was 92.1% 
and specificity was 92.6%. Few studies in the literature used these 
scales, which limits the comparison of results.  
ASQ, conversely, has been widely used. Two studies conducted 
by our research team demonstrated its applicability. A study that 
evaluated all patients with Down syndrome in the city of Curitiba, 
southern Brazil8, showed that ASQ was capable of identifying all 
cases of PDD in that population. In the first epidemiologic study of 
PDD in Latin America, a prevalence of 0.3% was found2. In both 
studies, ASQ was a reliable instrument that discriminated PDD 
cases from non-PDD cases.
The validation of an instrument with good psychometric 
properties is essential for the advancement of research and 
public health programs in Brazil. The translated version of 
ASQ was appropriate for use in our country. The formerly ASQ, 
currently Social Communication Questionnaire (SCQ)14, a 
copyrighted instrument, however, is one of its limitations, since 
its use is not free of costs.
Conclusions
The current study is a preliminary indication of validity. Other 
limitations were related to sample size, lack of IQ scores of the 
subjects, and lack of gold-standard diagnostic instruments. Further 
studies are required to improve the validation proprieties of the 
Brazilian version of ASQ.
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